118 related articles for article (PubMed ID: 27637326)
1. BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2017 Oct; 173():139-147. PubMed ID: 27637326
[TBL] [Abstract][Full Text] [Related]
2. The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
Harrison JS; Wang X; Studzinski GP
Oncotarget; 2016 Jun; 7(24):36447-36460. PubMed ID: 27144333
[TBL] [Abstract][Full Text] [Related]
3. JNK1 as a signaling node in VDR-BRAF induction of cell death in AML.
Wang X; Beute WK; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2018 Mar; 177():149-154. PubMed ID: 28765039
[TBL] [Abstract][Full Text] [Related]
4. Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.
Wang X; Nachliely M; Harrison JS; Danilenko M; Studzinski GP
J Steroid Biochem Mol Biol; 2019 Mar; 187():166-173. PubMed ID: 30508644
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Wang X; Harrison JS; Studzinski GP
J Steroid Biochem Mol Biol; 2016 Nov; 164():72-78. PubMed ID: 26319201
[TBL] [Abstract][Full Text] [Related]
7. Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
Wang X; Dawod A; Nachliely M; Harrison JS; Danilenko M; Studzinski GP
J Cell Physiol; 2020 Jan; 235(1):573-586. PubMed ID: 31245853
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.
Gocek E; Wang X; Liu X; Liu CG; Studzinski GP
Cancer Res; 2011 Oct; 71(19):6230-9. PubMed ID: 21816906
[TBL] [Abstract][Full Text] [Related]
9. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.
Zhang W; Konopleva M; Ruvolo VR; McQueen T; Evans RL; Bornmann WG; McCubrey J; Cortes J; Andreeff M
Leukemia; 2008 Apr; 22(4):808-18. PubMed ID: 18200035
[TBL] [Abstract][Full Text] [Related]
11. Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells.
Grundy M; Jones T; Elmi L; Hall M; Graham A; Russell N; Pallis M
PLoS One; 2018; 13(5):e0196805. PubMed ID: 29723246
[TBL] [Abstract][Full Text] [Related]
12. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.
Li X; Yan X; Guo W; Huang X; Huang J; Yu M; Ma Z; Xu Y; Huang S; Li C; Zhou Y; Jin J
Biomed Pharmacother; 2017 Jun; 90():699-704. PubMed ID: 28419965
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
[TBL] [Abstract][Full Text] [Related]
15. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
[TBL] [Abstract][Full Text] [Related]
16. Optimal AraC-Cytotoxicity to AML Cells Requires ERK5 Activity.
Zheng R; Studzinski GP
J Cell Biochem; 2017 Jun; 118(6):1583-1589. PubMed ID: 27922189
[TBL] [Abstract][Full Text] [Related]
17. n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation.
Picou F; Debeissat C; Bourgeais J; Gallay N; Ferrié E; Foucault A; Ravalet N; Maciejewski A; Vallet N; Ducrocq E; Haddaoui L; Domenech J; Hérault O; Gyan E
Pharmacol Res; 2018 Oct; 136():45-55. PubMed ID: 30142422
[TBL] [Abstract][Full Text] [Related]
18. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity.
Yang C; Boyson CA; Di Liberto M; Huang X; Hannah J; Dorn DC; Moore MA; Chen-Kiang S; Zhou P
Cancer Res; 2015 May; 75(9):1838-45. PubMed ID: 25744718
[TBL] [Abstract][Full Text] [Related]
19. The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells.
Chen-Deutsch X; Kutner A; Harrison JS; Studzinski GP
Leuk Res; 2012 Jul; 36(7):884-8. PubMed ID: 22541691
[TBL] [Abstract][Full Text] [Related]
20. Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
Tsunaka M; Shinki H; Koyama T
PLoS One; 2017; 12(4):e0175765. PubMed ID: 28406995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
